Astellas Pharma Inc. (ALPMF)
OTCMKTS · Delayed Price · Currency is USD
16.33
+0.27 (1.71%)
At close: Feb 10, 2026
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $29.41 billion as of February 11, 2026. Its market cap has increased by 69.55% in one year.
Market Cap
29.41B
Enterprise Value
32.47B
Revenue
13.14B
Ranking
n/a
PE Ratio
14.28
Stock Price
$16.33
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 29.41B, an increase of 322.34%. That is a compound annual growth rate of 4.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 29.41B | 22.57% |
| Dec 30, 2025 | 23.99B | 37.26% |
| Dec 30, 2024 | 17.48B | -18.50% |
| Dec 29, 2023 | 21.44B | -22.67% |
| Dec 30, 2022 | 27.73B | -7.87% |
| Dec 30, 2021 | 30.10B | 5.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 766.76M |
| Glass House Brands | 761.25M |
| Elite Pharmaceuticals | 473.68M |
| Nika Pharmaceuticals | 403.38M |
| Northwest Biotherapeutics | 399.44M |
| American Oncology Network | 377.98M |
| OpGen | 337.95M |
| CytoDyn | 304.50M |